Last 12 months
Inside the activity.
15 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 4 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 4 | 0 |
| Oct 2026 | 3 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2021 Filed Feb 17, 2021 23:47 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,560 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-21-004318 · doc1.xml · derivative · entry 5 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,540 Underlying: Ordinary Shares · 7,560 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: The original grant was for 36,000 shares, of which 28,460 shares have been exercised and sold. The remaining shares underlying the option (7,540 shares) are fully vested and exercisable as of the date hereof. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:47 UTC |
Zago Wagner M.Chief Scientific Officer
|
SaleOrdinary Shares, par value $0.01 per share | 18,750 | $20.00 | $375,007.50 |
DisclosureSEC source: 0001567619-21-004318 · doc1.xml · nonDerivative · entry 4 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $20.00 to $20.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:47 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 18,750 | $13.53 | $253,687.50 |
DisclosureSEC source: 0001567619-21-004318 · doc1.xml · nonDerivative · entry 3 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:47 UTC |
Zago Wagner M.Chief Scientific Officer
|
SaleOrdinary Shares, par value $0.01 per share | 7,560 | $17.07 | $129,049.20 |
DisclosureSEC source: 0001567619-21-004318 · doc1.xml · nonDerivative · entry 2 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:47 UTC |
Zago Wagner M.Chief Scientific Officer
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 7,560 | $6.41 | $48,459.60 |
DisclosureSEC source: 0001567619-21-004318 · doc1.xml · nonDerivative · entry 1 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 18:39 UTC |
Karp Carol D.Chief Regulatory Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 45,112 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004307 · doc1.xml · derivative · entry 4 Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,112 Underlying: Ordinary Shares · 45,112 shares Expires 2028-02-21 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 60,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018. In exchange, the reporting person received a replacement option, for 45,112 ordinary shares, having an exercise price of $22.85 per ordinary share. F5 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 47/48 of the total number of shares subject to the option on the one year anniversary of the date of grant and with respect to 1/48 of the total number of shares subject to the option on February 21, 2022, subject to the reporting person's continued service with the issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 18:39 UTC |
Karp Carol D.Chief Regulatory Officer
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 60,000 | Not disclosed Strike: $33.10 | Not disclosed |
DisclosureSEC source: 0001567619-21-004307 · doc1.xml · derivative · entry 3 Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 60,000 shares Expires 2028-02-21 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 60,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018. In exchange, the reporting person received a replacement option, for 45,112 ordinary shares, having an exercise price of $22.85 per ordinary share. F3 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the reporting person's continued employment with the issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 18:39 UTC |
Karp Carol D.Chief Regulatory Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 51,282 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004307 · doc1.xml · derivative · entry 2 Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,282 Underlying: Ordinary Shares · 51,282 shares Expires 2026-12-14 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 100,000 of the issuer's ordinary shares granted to the reporting person on December 14, 2016. In exchange, the reporting person received a replacement option, for 51,282 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 18:39 UTC |
Karp Carol D.Chief Regulatory Officer
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $52.78 | Not disclosed |
DisclosureSEC source: 0001567619-21-004307 · doc1.xml · derivative · entry 1 Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 100,000 shares Expires 2026-12-14 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 100,000 of the issuer's ordinary shares granted to the reporting person on December 14, 2016. In exchange, the reporting person received a replacement option, for 51,282 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:46 UTC |
Nguyen TranSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 60,150 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004317 · doc1.xml · derivative · entry 8 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,150 Underlying: Ordinary Shares · 60,150 shares Expires 2028-02-21 F7 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 80,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018. In exchange, the reporting person received a replacement option, for 60,150 ordinary shares, having an exercise price of $22.85 per ordinary share. F8 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 47/48 of the total number of shares subject to the option on the one year anniversary of the date of grant and with respect to 1/48 of the total number of shares subject to the option on February 21, 2022, subject to the reporting person's continued service with the issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:46 UTC |
Nguyen TranSee Remarks
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 80,000 | Not disclosed Strike: $33.10 | Not disclosed |
DisclosureSEC source: 0001567619-21-004317 · doc1.xml · derivative · entry 7 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 80,000 shares Expires 2028-02-21 F7 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 80,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018. In exchange, the reporting person received a replacement option, for 60,150 ordinary shares, having an exercise price of $22.85 per ordinary share. F6 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the reporting person's continued employment with the issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:46 UTC |
Nguyen TranSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 39,062 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004317 · doc1.xml · derivative · entry 6 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,062 Underlying: Ordinary Shares · 39,062 shares Expires 2027-02-22 F5 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 75,000 of the issuer's ordinary shares granted to the reporting person on February 22, 2017. In exchange, the reporting person received a replacement option, for 39,062 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:46 UTC |
Nguyen TranSee Remarks
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 75,000 | Not disclosed Strike: $55.00 | Not disclosed |
DisclosureSEC source: 0001567619-21-004317 · doc1.xml · derivative · entry 5 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 75,000 shares Expires 2027-02-22 F5 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 75,000 of the issuer's ordinary shares granted to the reporting person on February 22, 2017. In exchange, the reporting person received a replacement option, for 39,062 ordinary shares, having an exercise price of $22.85 per ordinary share. F4 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 22, 2018 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the reporting person's continued employment with the issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:46 UTC |
Nguyen TranSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,625 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004317 · doc1.xml · derivative · entry 4 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,625 Underlying: Ordinary Shares · 40,625 shares Expires 2026-02-24 F2 · price: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:46 UTC |
Nguyen TranSee Remarks
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 65,000 | Not disclosed Strike: $34.61 | Not disclosed |
DisclosureSEC source: 0001567619-21-004317 · doc1.xml · derivative · entry 3 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 65,000 shares Expires 2026-02-24 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 65,000 of the issuer's ordinary shares granted to the reporting person on February 24, 2016. In exchange, the reporting person received a replacement option, for 40,625 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:46 UTC |
Nguyen TranSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004317 · doc1.xml · derivative · entry 2 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires 2025-03-11 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 55,000 of the issuer's ordinary shares granted to the reporting person on March 11, 2015. In exchange, the reporting person received a replacement option, for 50,000 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:46 UTC |
Nguyen TranSee Remarks
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 55,000 | Not disclosed Strike: $27.81 | Not disclosed |
DisclosureSEC source: 0001567619-21-004317 · doc1.xml · derivative · entry 1 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 55,000 shares Expires 2025-03-11 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 55,000 of the issuer's ordinary shares granted to the reporting person on March 11, 2015. In exchange, the reporting person received a replacement option, for 50,000 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 18:40 UTC |
HENNEY CHRISTOPHER SDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,315 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004308 · doc1.xml · derivative · entry 6 HENNEY CHRISTOPHER S · CIK 0001242880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Underlying: Ordinary Shares · 6,315 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 18:40 UTC |
HENNEY CHRISTOPHER SDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $56.23 | Not disclosed |
DisclosureSEC source: 0001567619-21-004308 · doc1.xml · derivative · entry 5 HENNEY CHRISTOPHER S · CIK 0001242880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,000 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 18:40 UTC |
HENNEY CHRISTOPHER SDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,426 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004308 · doc1.xml · derivative · entry 4 HENNEY CHRISTOPHER S · CIK 0001242880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,426 Underlying: Ordinary Shares · 8,426 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 18:40 UTC |
HENNEY CHRISTOPHER SDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $42.50 | Not disclosed |
DisclosureSEC source: 0001567619-21-004308 · doc1.xml · derivative · entry 3 HENNEY CHRISTOPHER S · CIK 0001242880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 18:40 UTC |
HENNEY CHRISTOPHER SDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,803 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004308 · doc1.xml · derivative · entry 2 HENNEY CHRISTOPHER S · CIK 0001242880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,803 Underlying: Ordinary Shares · 9,803 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 18:40 UTC |
HENNEY CHRISTOPHER SDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $34.04 | Not disclosed |
DisclosureSEC source: 0001567619-21-004308 · doc1.xml · derivative · entry 1 HENNEY CHRISTOPHER S · CIK 0001242880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:43 UTC |
Ekman LarsDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,315 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004313 · doc1.xml · derivative · entry 6 Ekman Lars · CIK 0001376117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Underlying: Ordinary Shares · 6,315 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:43 UTC |
Ekman LarsDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $56.23 | Not disclosed |
DisclosureSEC source: 0001567619-21-004313 · doc1.xml · derivative · entry 5 Ekman Lars · CIK 0001376117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,000 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:43 UTC |
Ekman LarsDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,426 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004313 · doc1.xml · derivative · entry 4 Ekman Lars · CIK 0001376117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,426 Underlying: Ordinary Shares · 8,426 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:43 UTC |
Ekman LarsDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $42.50 | Not disclosed |
DisclosureSEC source: 0001567619-21-004313 · doc1.xml · derivative · entry 3 Ekman Lars · CIK 0001376117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:43 UTC |
Ekman LarsDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,803 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004313 · doc1.xml · derivative · entry 2 Ekman Lars · CIK 0001376117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,803 Underlying: Ordinary Shares · 9,803 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:43 UTC |
Ekman LarsDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $34.04 | Not disclosed |
DisclosureSEC source: 0001567619-21-004313 · doc1.xml · derivative · entry 1 Ekman Lars · CIK 0001376117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
Cooke ShaneDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,315 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 6 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Underlying: Ordinary Shares · 6,315 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
Cooke ShaneDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $56.23 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 5 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,000 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
Cooke ShaneDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,426 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 4 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,426 Underlying: Ordinary Shares · 8,426 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
Cooke ShaneDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $42.50 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
Cooke ShaneDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,803 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,803 Underlying: Ordinary Shares · 9,803 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:45 UTC |
Cooke ShaneDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $34.04 | Not disclosed |
DisclosureSEC source: 0001567619-21-004316 · doc1.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 00:14 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseOrdinary Shares | 282,800 | $20.08 | $5,678,510.88 |
DisclosureSEC source: 0001567619-21-004320 · doc1.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 9,771,940 F3 · shares: All of the Ordinary Shares purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 8,198,387 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 00:14 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseOrdinary Shares | 62,500 | $20.50 | $1,281,250.00 |
DisclosureSEC source: 0001567619-21-004320 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 9,489,140 F2 · shares: All of the Ordinary Shares purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 7,915,587 Ordinary Shares. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:44 UTC |
Tripuraneni RadhikaChief Development Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 37,037 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004314 · doc1.xml · derivative · entry 2 Tripuraneni Radhika · CIK 0001761114 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,037 Underlying: Ordinary Shares · 37,037 shares Expires 2028-04-02 F2 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 of the issuer's ordinary shares granted to the reporting person on April 2, 2018. In exchange, the reporting person received a replacement option, for 37,037 ordinary shares, having an exercise price of $22.85 per ordinary share. F3 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 46/48 of the total number of shares subject to the option on the one year anniversary of the date of grant, with respect to 1/48 of the total number of shares subject to the option on March 2, 2022 and with respect to 1/48 of the total number of shares subject to the option on April 2, 2022, subject to the reporting person's continued service with the issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:44 UTC |
Tripuraneni RadhikaChief Development Officer
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 50,000 | Not disclosed Strike: $35.24 | Not disclosed |
DisclosureSEC source: 0001567619-21-004314 · doc1.xml · derivative · entry 1 Tripuraneni Radhika · CIK 0001761114 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 50,000 shares Expires 2028-04-02 F2 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 of the issuer's ordinary shares granted to the reporting person on April 2, 2018. In exchange, the reporting person received a replacement option, for 37,037 ordinary shares, having an exercise price of $22.85 per ordinary share. F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on April 2, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Harfstrand Karl Anders OlofDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,315 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004312 · doc1.xml · derivative · entry 6 Harfstrand Karl Anders Olof · CIK 0001646451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Underlying: Ordinary Shares · 6,315 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Harfstrand Karl Anders OlofDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $56.23 | Not disclosed |
DisclosureSEC source: 0001567619-21-004312 · doc1.xml · derivative · entry 5 Harfstrand Karl Anders Olof · CIK 0001646451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,000 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Harfstrand Karl Anders OlofDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,426 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004312 · doc1.xml · derivative · entry 4 Harfstrand Karl Anders Olof · CIK 0001646451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,426 Underlying: Ordinary Shares · 8,426 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Harfstrand Karl Anders OlofDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $42.50 | Not disclosed |
DisclosureSEC source: 0001567619-21-004312 · doc1.xml · derivative · entry 3 Harfstrand Karl Anders Olof · CIK 0001646451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Harfstrand Karl Anders OlofDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,873 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004312 · doc1.xml · derivative · entry 2 Harfstrand Karl Anders Olof · CIK 0001646451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,873 Underlying: Ordinary Shares · 15,873 shares Expires 2025-06-29 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's ordinary shares granted to the reporting person on June 29, 2015. In exchange, the reporting person received a replacement option, for 15,873 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Harfstrand Karl Anders OlofDirector
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $49.60 | Not disclosed |
DisclosureSEC source: 0001567619-21-004312 · doc1.xml · derivative · entry 1 Harfstrand Karl Anders Olof · CIK 0001646451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 30,000 shares Expires 2025-06-29 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's ordinary shares granted to the reporting person on June 29, 2015. In exchange, the reporting person received a replacement option, for 15,873 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Walker Karin LChief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,796 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004311 · doc1.xml · derivative · entry 8 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,796 Underlying: Ordinary Shares · 18,796 shares Expires 2028-02-21 F7 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 25,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018. In exchange, the reporting person received a replacement option, for 18,796 ordinary shares, having an exercise price of $22.85 per ordinary share. F8 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 47/48 of the total number of shares subject to the option on the one year anniversary of the date of grant and with respect to 1/48 of the total number of shares subject to the option on February 21, 2022, subject to the reporting person's continued service with the issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Walker Karin LChief Accounting Officer
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 25,000 | Not disclosed Strike: $33.10 | Not disclosed |
DisclosureSEC source: 0001567619-21-004311 · doc1.xml · derivative · entry 7 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25,000 shares Expires 2028-02-21 F7 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 25,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018. In exchange, the reporting person received a replacement option, for 18,796 ordinary shares, having an exercise price of $22.85 per ordinary share. F6 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Walker Karin LChief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,625 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004311 · doc1.xml · derivative · entry 6 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Ordinary Shares · 15,625 shares Expires 2027-02-22 F5 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's ordinary shares granted to the reporting person on February 22, 2017. In exchange, the reporting person received a replacement option, for 15,625 ordinary shares, having an exercise price of $22.85 per ordinary share. F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Walker Karin LChief Accounting Officer
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $55.00 | Not disclosed |
DisclosureSEC source: 0001567619-21-004311 · doc1.xml · derivative · entry 5 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 30,000 shares Expires 2027-02-22 F5 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's ordinary shares granted to the reporting person on February 22, 2017. In exchange, the reporting person received a replacement option, for 15,625 ordinary shares, having an exercise price of $22.85 per ordinary share. F4 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 22, 2018 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Walker Karin LChief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,625 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004311 · doc1.xml · derivative · entry 4 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Ordinary Shares · 15,625 shares Expires 2026-02-24 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 25,000 of the issuer's ordinary shares granted to the reporting person on February 24, 2016. In exchange, the reporting person received a replacement option, for 15,625 ordinary shares, having an exercise price of $22.85 per ordinary share. F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.